Eprenetapopt Completed Phase 2 Trials for High-grade Serous Ovarian Carcinoma (HGSOC) Treatment

Indications	Status	Purpose	Phase
DBCOND0140551 (High-grade Serous Ovarian Carcinoma (HGSOC))	Completed	Treatment	2

clinicaltrials.gov Identifier	Title	Drugs
NCT03268382	p53 Activation in Platinum-Resistant High Grade Serous Ovarian Cancer, a Study of PLD With APR-246	Doxorubicin (DB00997) Eprenetapopt (DB11684)